Keywords
nicotine dependence
varenicline
tobacco use cessation products
Abstract
Objective: This study aimed to determine the frequency of smoking cessation and affecting factors in patients who applied to the smoking cessation clinic.
Method: This study included smokers aged 18 years and over who applied to the Chest Diseases Clinic Smoking Cessation Outpatient Clinic between 1 April 2019 and 31 July 2019. All participants were evaluated with a sociodemographic questionnaire, Fagerström Test for Nicotine Dependence (FNBT) and Beck Depression Scale during the initial outpatient clinic admission. Subsequently, smoking cessation treatment was started and all participants were called at 6 and 12 months and their smoking cessation status was questioned. Smokers who did never smoked for the last 1 year were accepted as ex-smokers.
Results: A total of 270 participants were included in the study, and 48 (19.5%) of the participants were found to quit smoking at the end of one year. There was no significant difference between ex-smokers and current smokers in terms of age, gender, marital status, educational level, employment status, income level, duration of smoking, FNDT and Beck’s depression scores. However, smoking status in the phone call at 6-month was found to be an important factor affecting the success of smoking cessation at 12 months.
Conclusion: Although the success rate for individuals who want to quit smoking is quite low in the literature, accessing appropriate pharmacological treatment may increase the success of smoking cessation. Additionally, it has been observed that ex-smokers quit smoking, especially in the first 6 months.
References
Kanatsız B, Başlılar Ş, ŞaylanB, et al. Evaluation of the factors affecting success rate and medical treatments in smoking cessation. Eurasian Journal of Family Medicine 2017; 6(2): 65-71.
Arpacıoğlu S, Ünübol B, Bilici R, Erzincan E. Results of smoking cessation clinic in Erenköy Mental and Neurological Diseases Training and Research Hospital: an investigation into the effects of cognitive behavioral intervention and pharmacotherapy. Addicta: The Turkish Journal on Addictions 2019; 6(4): 295-314.
Benowıtz Neal L. Nicotine addiction. N Engl J Med 2010; 362(24): 2295-2303.
Blak Betina T, Wilson K, Metcalfe M, et al. Evaluation of varenicline as an aid to smoking cessation in UK general practice–a thın database study. Curr Med Res Opin 2010; 26(4): 861-870.
World Health Organization. Global Report on Trends in Prevalence on Tobacco Smoking 2000-2025, Second Edition. Geneva: World Health Organization, 2018.
World Health Organization. Report On The Global Tobacco Epıdemic. Offer Help To Quit Tobacco Use. Geneva: World Health Organization, 2019 .
Turkish Ministry of Health. General Directorate of Public Health. https:// hsgm.saglik.gov.tr/tr/bagimliliklamucadele-haberler/sigara-birakma-hizmetleri.html. (Accessed date:5/22/2021).
Sağlam L. Clinical evaluation of nicotine dependence. Güncel Göğüs Hastalıkları Serisi 2017; 4(1): 78-89.
Uysal MA, Kadakal F, Karşıdağ Ç, et al. Fagerstrom test for nicotine dependence:reliability in a Turkish sample and factor analysis. Tüberk Toraks 2004; 52(2): 115-121.
Hisli N. Beck Depresyon enventerinin üniversite öğrencileri için geçerlilik ve güvenilirliği. Psikoloji Dergisi 1989; 7(23): 3-13.
Benli AR, Erturhan S, Oruc MA, et al. A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme. Tob Induc Dis. 2017; 15: 10.
Sağlam L. Investigation of the results of asmoking cessation clinic and the factors associated with success. Turk J Med Sci 2012; 42(3): 515-522.
Poulsen PB, Spillemose H, Nielsen G, et al. Real-life effectiveness of smokingcessation treatments in general practice clinics in Denmark. The Escape Smoke project. Respir Med 2015; 109(2): 218-227.
Argüder E, Karalezli A, Hezer H, et al. Factors affecting the success of smoking cessation. Turk Toraks Derg 2013; 14(3): 81-87.
Yaşar Z, Kar Kurt Ö, Talay F, Kargı A. One-year follow-up results of smoking cessation outpatient clinic: factors a ecting the cessation of smoking. Eurasian J Pulmonol 2014; 16(2): 99-104.
Raherison C, Marjary A, Valpromy B, et al. Evaluation of smoking cessation success in adult. Respir Med 2005; 99(10): 1303-1310.
Blok DJ, de Vlas SJ, van Empelen P, van Lenthe FJ. The role of smoking in social networks on smoking cessation and relapse among adults: a longitudinal study. Prev Med 2017; 99: 105-110.
Janson C, Künzli N, de Marco R, et al. Changes in active and passive smoking in the European Community Respiratory Health Survey. Eur Respir J 2006; 27(3): 517-524.
Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008; 179(2): 135-144.
Cahıll K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta‐analysis. Cochrane Database Syst Rev 2013 (5): CD009329.
Hughes JR, Stead LF, Hartmann‐Boyce J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014 (1): CD000031.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Journal of Dependence